Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

Sponsor
Iraqi Board of medical specialties (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05725460
Collaborator
(none)
40
2
8

Study Details

Study Description

Brief Summary

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Condition or Disease Intervention/Treatment Phase
  • Procedure: dextrose 5% median nerve hydrodissection
N/A

Detailed Description

in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Dextrose 5% in Comparison With Steroid in Median Nerve Ultrasound Guided Hydrodissection in Patients With Carpal Tunnel Syndrome
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: dextrose 5%

10 mls of dextrose under ultrasound to separate the median nerve from adjacent structures

Procedure: dextrose 5% median nerve hydrodissection
planned to be a good alternative to steroid hydrodissection

Active Comparator: steroid

10 mls of steroid used to separate the median nerve from adjacent structures

Procedure: dextrose 5% median nerve hydrodissection
planned to be a good alternative to steroid hydrodissection

Outcome Measures

Primary Outcome Measures

  1. pain relief in 2 weeks follow up [6 months]

    difference in sensory and functional symptoms post median nerve hydrodissection using dextrose and compare this effect with steroid population arm using Boston questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

severe carpal tunnel syndrome failed medical management -

Exclusion Criteria:

previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus

-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Iraqi Board of medical specialties

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Iraqi Board of medical specialties
ClinicalTrials.gov Identifier:
NCT05725460
Other Study ID Numbers:
  • iraqiboard
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023